nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—ABCC10—Estradiol—osteoporosis	0.181	0.272	CbGbCtD
Tenofovir—ABCC4—Conjugated Estrogens—osteoporosis	0.0992	0.149	CbGbCtD
Tenofovir—ABCC2—Ethinyl Estradiol—osteoporosis	0.0804	0.12	CbGbCtD
Tenofovir—SLC22A8—Conjugated Estrogens—osteoporosis	0.062	0.0929	CbGbCtD
Tenofovir—ABCC2—Conjugated Estrogens—osteoporosis	0.059	0.0884	CbGbCtD
Tenofovir—SLC22A8—Estradiol—osteoporosis	0.0544	0.0816	CbGbCtD
Tenofovir—CYP1A2—Estropipate—osteoporosis	0.0465	0.0697	CbGbCtD
Tenofovir—SLC22A6—Conjugated Estrogens—osteoporosis	0.0432	0.0647	CbGbCtD
Tenofovir—CYP1A2—Conjugated Estrogens—osteoporosis	0.022	0.033	CbGbCtD
Tenofovir—CYP1A2—Estradiol—osteoporosis	0.0193	0.0289	CbGbCtD
Tenofovir—ABCC4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00615	0.0661	CbGpPWpGaD
Tenofovir—ABCC2—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00518	0.0557	CbGpPWpGaD
Tenofovir—AK2—Nucleotide metabolism—ATIC—osteoporosis	0.00486	0.0522	CbGpPWpGaD
Tenofovir—AK2—Nucleotide metabolism—PNP—osteoporosis	0.00486	0.0522	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—PRDX3—osteoporosis	0.00364	0.0391	CbGpPWpGaD
Tenofovir—NME2—Nucleotide metabolism—ATIC—osteoporosis	0.00337	0.0362	CbGpPWpGaD
Tenofovir—NME2—Nucleotide metabolism—PNP—osteoporosis	0.00337	0.0362	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—PRDX3—osteoporosis	0.00276	0.0297	CbGpPWpGaD
Tenofovir—NME1—Nucleotide metabolism—ATIC—osteoporosis	0.00255	0.0274	CbGpPWpGaD
Tenofovir—NME1—Nucleotide metabolism—PNP—osteoporosis	0.00255	0.0274	CbGpPWpGaD
Tenofovir—NME1—E-cadherin signaling in the nascent adherens junction—RAP1A—osteoporosis	0.00255	0.0274	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—GAPDH—osteoporosis	0.00184	0.0198	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—ENO1—osteoporosis	0.00145	0.0156	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—GAPDH—osteoporosis	0.0014	0.015	CbGpPWpGaD
Tenofovir—NME1—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00139	1	CbGdCrCtD
Tenofovir—AK2—Nucleotide metabolism—GPX1—osteoporosis	0.00138	0.0148	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—WDR1—osteoporosis	0.00123	0.0133	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—WDR1—osteoporosis	0.00118	0.0126	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—ENO1—osteoporosis	0.0011	0.0118	CbGpPWpGaD
Tenofovir—ABCC4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000982	0.0106	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—CAP1—osteoporosis	0.000976	0.0105	CbGpPWpGaD
Tenofovir—NME2—Nucleotide metabolism—GPX1—osteoporosis	0.000954	0.0102	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—CAP1—osteoporosis	0.00093	0.00999	CbGpPWpGaD
Tenofovir—ABCC2—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000828	0.0089	CbGpPWpGaD
Tenofovir—NME1—Nucleotide metabolism—GPX1—osteoporosis	0.000723	0.00776	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—PLEK—osteoporosis	0.000709	0.00762	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—PLEK—osteoporosis	0.000675	0.00726	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000671	0.00721	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—TLN1—osteoporosis	0.000611	0.00657	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—VCL—osteoporosis	0.000603	0.00648	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—TLN1—osteoporosis	0.000582	0.00626	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—VCL—osteoporosis	0.000574	0.00617	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.000548	0.00588	CbGpPWpGaD
Tenofovir—AK2—Metabolism—FDPS—osteoporosis	0.000509	0.00547	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PKM—osteoporosis	0.000509	0.00547	CbGpPWpGaD
Tenofovir—ABCC4—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.000497	0.00534	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PGLS—osteoporosis	0.000482	0.00518	CbGpPWpGaD
Tenofovir—AK2—Metabolism—GPD2—osteoporosis	0.000482	0.00518	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000477	0.00513	CbGpPWpGaD
Tenofovir—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000476	0.00511	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—FGA—osteoporosis	0.000457	0.00491	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PNP—osteoporosis	0.000441	0.00474	CbGpPWpGaD
Tenofovir—AK2—Metabolism—ATIC—osteoporosis	0.000441	0.00474	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.000435	0.00468	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.000433	0.00465	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—FGB—osteoporosis	0.000416	0.00447	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—MYC—osteoporosis	0.000403	0.00433	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	0.000396	0.00425	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000385	0.00414	CbGpPWpGaD
Tenofovir—AK2—Metabolism—OXCT1—osteoporosis	0.000375	0.00403	CbGpPWpGaD
Tenofovir—AK2—Metabolism—CA2—osteoporosis	0.000375	0.00403	CbGpPWpGaD
Tenofovir—AK2—Metabolism—MGLL—osteoporosis	0.000365	0.00393	CbGpPWpGaD
Tenofovir—Anxiety—Risedronate—osteoporosis	0.000365	0.00153	CcSEcCtD
Tenofovir—Pain—Ibandronate—osteoporosis	0.000364	0.00153	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000363	0.00153	CcSEcCtD
Tenofovir—Pruritus—Etidronic acid—osteoporosis	0.000363	0.00152	CcSEcCtD
Tenofovir—Gastrointestinal pain—Estropipate—osteoporosis	0.000363	0.00152	CcSEcCtD
Tenofovir—Decreased appetite—Calcitriol—osteoporosis	0.000362	0.00152	CcSEcCtD
Tenofovir—Mental disorder—Conjugated Estrogens—osteoporosis	0.000362	0.00152	CcSEcCtD
Tenofovir—Back pain—Zoledronate—osteoporosis	0.000361	0.00152	CcSEcCtD
Tenofovir—Neuropathy peripheral—Estradiol—osteoporosis	0.000361	0.00151	CcSEcCtD
Tenofovir—Malnutrition—Conjugated Estrogens—osteoporosis	0.000359	0.00151	CcSEcCtD
Tenofovir—Gastrointestinal pain—Alendronate—osteoporosis	0.000358	0.0015	CcSEcCtD
Tenofovir—Pain—Calcitriol—osteoporosis	0.000356	0.0015	CcSEcCtD
Tenofovir—Flatulence—Conjugated Estrogens—osteoporosis	0.000354	0.00149	CcSEcCtD
Tenofovir—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000353	0.00148	CcSEcCtD
Tenofovir—NME2—Metabolism—PKM—osteoporosis	0.000353	0.00379	CbGpPWpGaD
Tenofovir—NME2—Metabolism—FDPS—osteoporosis	0.000353	0.00379	CbGpPWpGaD
Tenofovir—Gastrointestinal pain—Raloxifene—osteoporosis	0.000352	0.00148	CcSEcCtD
Tenofovir—Diarrhoea—Etidronic acid—osteoporosis	0.000351	0.00147	CcSEcCtD
Tenofovir—Haematuria—Estradiol—osteoporosis	0.000351	0.00147	CcSEcCtD
Tenofovir—Abdominal pain—Estropipate—osteoporosis	0.000351	0.00147	CcSEcCtD
Tenofovir—Body temperature increased—Estropipate—osteoporosis	0.000351	0.00147	CcSEcCtD
Tenofovir—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00035	0.00147	CcSEcCtD
Tenofovir—Hepatobiliary disease—Estradiol—osteoporosis	0.000348	0.00146	CcSEcCtD
Tenofovir—Gastrointestinal pain—Ibandronate—osteoporosis	0.000348	0.00146	CcSEcCtD
Tenofovir—Myalgia—Pamidronate—osteoporosis	0.000348	0.00146	CcSEcCtD
Tenofovir—Arthralgia—Pamidronate—osteoporosis	0.000348	0.00146	CcSEcCtD
Tenofovir—Back pain—Conjugated Estrogens—osteoporosis	0.000348	0.00146	CcSEcCtD
Tenofovir—Anxiety—Pamidronate—osteoporosis	0.000347	0.00145	CcSEcCtD
Tenofovir—Body temperature increased—Alendronate—osteoporosis	0.000346	0.00145	CcSEcCtD
Tenofovir—Abdominal pain—Alendronate—osteoporosis	0.000346	0.00145	CcSEcCtD
Tenofovir—Sinusitis—Estradiol—osteoporosis	0.000345	0.00145	CcSEcCtD
Tenofovir—Nervous system disorder—Risedronate—osteoporosis	0.000344	0.00144	CcSEcCtD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.000344	0.00369	CbGpPWpGaD
Tenofovir—Angioedema—Zoledronate—osteoporosis	0.000341	0.00143	CcSEcCtD
Tenofovir—Skin disorder—Risedronate—osteoporosis	0.000341	0.00143	CcSEcCtD
Tenofovir—Gastrointestinal pain—Calcitriol—osteoporosis	0.000341	0.00143	CcSEcCtD
Tenofovir—Abdominal pain—Raloxifene—osteoporosis	0.00034	0.00143	CcSEcCtD
Tenofovir—Body temperature increased—Raloxifene—osteoporosis	0.00034	0.00143	CcSEcCtD
Tenofovir—Abdominal pain—Ibandronate—osteoporosis	0.000337	0.00141	CcSEcCtD
Tenofovir—Body temperature increased—Ibandronate—osteoporosis	0.000337	0.00141	CcSEcCtD
Tenofovir—NME2—Metabolism—PGLS—osteoporosis	0.000334	0.00359	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GPD2—osteoporosis	0.000334	0.00359	CbGpPWpGaD
Tenofovir—Hepatitis—Estradiol—osteoporosis	0.00033	0.00139	CcSEcCtD
Tenofovir—Abdominal pain—Calcitriol—osteoporosis	0.000329	0.00138	CcSEcCtD
Tenofovir—Body temperature increased—Calcitriol—osteoporosis	0.000329	0.00138	CcSEcCtD
Tenofovir—Angioedema—Conjugated Estrogens—osteoporosis	0.000328	0.00138	CcSEcCtD
Tenofovir—Hypersensitivity—Estropipate—osteoporosis	0.000327	0.00137	CcSEcCtD
Tenofovir—Nervous system disorder—Pamidronate—osteoporosis	0.000327	0.00137	CcSEcCtD
Tenofovir—Urinary tract disorder—Estradiol—osteoporosis	0.000326	0.00137	CcSEcCtD
Tenofovir—Vomiting—Etidronic acid—osteoporosis	0.000326	0.00137	CcSEcCtD
Tenofovir—Connective tissue disorder—Estradiol—osteoporosis	0.000325	0.00136	CcSEcCtD
Tenofovir—Urethral disorder—Estradiol—osteoporosis	0.000324	0.00136	CcSEcCtD
Tenofovir—Rash—Etidronic acid—osteoporosis	0.000324	0.00136	CcSEcCtD
Tenofovir—Dermatitis—Etidronic acid—osteoporosis	0.000323	0.00136	CcSEcCtD
Tenofovir—ABCC4—Ectoderm Differentiation—TNFRSF11B—osteoporosis	0.000323	0.00347	CbGpPWpGaD
Tenofovir—Hyperhidrosis—Pamidronate—osteoporosis	0.000322	0.00135	CcSEcCtD
Tenofovir—Hypersensitivity—Alendronate—osteoporosis	0.000322	0.00135	CcSEcCtD
Tenofovir—Headache—Etidronic acid—osteoporosis	0.000321	0.00135	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00032	0.00134	CcSEcCtD
Tenofovir—Asthenia—Estropipate—osteoporosis	0.000319	0.00134	CcSEcCtD
Tenofovir—Anorexia—Pamidronate—osteoporosis	0.000318	0.00133	CcSEcCtD
Tenofovir—Arthralgia—Zoledronate—osteoporosis	0.000318	0.00133	CcSEcCtD
Tenofovir—Chest pain—Zoledronate—osteoporosis	0.000318	0.00133	CcSEcCtD
Tenofovir—Myalgia—Zoledronate—osteoporosis	0.000318	0.00133	CcSEcCtD
Tenofovir—ABCC4—Ectoderm Differentiation—NFATC1—osteoporosis	0.000318	0.00341	CbGpPWpGaD
Tenofovir—Insomnia—Risedronate—osteoporosis	0.000317	0.00133	CcSEcCtD
Tenofovir—Anxiety—Zoledronate—osteoporosis	0.000317	0.00133	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000316	0.00132	CcSEcCtD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.000314	0.00338	CbGpPWpGaD
Tenofovir—Pruritus—Estropipate—osteoporosis	0.000314	0.00132	CcSEcCtD
Tenofovir—Asthenia—Alendronate—osteoporosis	0.000314	0.00132	CcSEcCtD
Tenofovir—Hypersensitivity—Ibandronate—osteoporosis	0.000314	0.00132	CcSEcCtD
Tenofovir—Dyspnoea—Risedronate—osteoporosis	0.000313	0.00131	CcSEcCtD
Tenofovir—AK2—Metabolism—IDH2—osteoporosis	0.000311	0.00334	CbGpPWpGaD
Tenofovir—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000311	0.0013	CcSEcCtD
Tenofovir—Fatigue—Ethinyl Estradiol—osteoporosis	0.00031	0.0013	CcSEcCtD
Tenofovir—Pruritus—Alendronate—osteoporosis	0.000309	0.0013	CcSEcCtD
Tenofovir—Dyspepsia—Risedronate—osteoporosis	0.000309	0.0013	CcSEcCtD
Tenofovir—Hypersensitivity—Calcitriol—osteoporosis	0.000307	0.00129	CcSEcCtD
Tenofovir—Chest pain—Conjugated Estrogens—osteoporosis	0.000306	0.00128	CcSEcCtD
Tenofovir—Arthralgia—Conjugated Estrogens—osteoporosis	0.000306	0.00128	CcSEcCtD
Tenofovir—Myalgia—Conjugated Estrogens—osteoporosis	0.000306	0.00128	CcSEcCtD
Tenofovir—NME2—Metabolism—PNP—osteoporosis	0.000306	0.00328	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ATIC—osteoporosis	0.000306	0.00328	CbGpPWpGaD
Tenofovir—Asthenia—Ibandronate—osteoporosis	0.000305	0.00128	CcSEcCtD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—MYC—osteoporosis	0.000305	0.00328	CbGpPWpGaD
Tenofovir—Anxiety—Conjugated Estrogens—osteoporosis	0.000305	0.00128	CcSEcCtD
Tenofovir—Nausea—Etidronic acid—osteoporosis	0.000305	0.00128	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000304	0.00128	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000304	0.00127	CcSEcCtD
Tenofovir—Diarrhoea—Estropipate—osteoporosis	0.000304	0.00127	CcSEcCtD
Tenofovir—ABCC4—Ectoderm Differentiation—WNT1—osteoporosis	0.000304	0.00326	CbGpPWpGaD
Tenofovir—Gastrointestinal disorder—Risedronate—osteoporosis	0.000303	0.00127	CcSEcCtD
Tenofovir—Fatigue—Risedronate—osteoporosis	0.000302	0.00127	CcSEcCtD
Tenofovir—Insomnia—Pamidronate—osteoporosis	0.000302	0.00127	CcSEcCtD
Tenofovir—Pruritus—Ibandronate—osteoporosis	0.000301	0.00126	CcSEcCtD
Tenofovir—Pain—Risedronate—osteoporosis	0.0003	0.00126	CcSEcCtD
Tenofovir—Diarrhoea—Alendronate—osteoporosis	0.000299	0.00126	CcSEcCtD
Tenofovir—Asthenia—Calcitriol—osteoporosis	0.000299	0.00125	CcSEcCtD
Tenofovir—Nervous system disorder—Zoledronate—osteoporosis	0.000299	0.00125	CcSEcCtD
Tenofovir—Immune system disorder—Estradiol—osteoporosis	0.000298	0.00125	CcSEcCtD
Tenofovir—Mediastinal disorder—Estradiol—osteoporosis	0.000298	0.00125	CcSEcCtD
Tenofovir—Dyspnoea—Pamidronate—osteoporosis	0.000297	0.00125	CcSEcCtD
Tenofovir—Skin disorder—Zoledronate—osteoporosis	0.000296	0.00124	CcSEcCtD
Tenofovir—Pruritus—Calcitriol—osteoporosis	0.000295	0.00124	CcSEcCtD
Tenofovir—Hyperhidrosis—Zoledronate—osteoporosis	0.000295	0.00124	CcSEcCtD
Tenofovir—CYP1A2—Estrogen Receptor Pathway—ESR1—osteoporosis	0.000294	0.00316	CbGpPWpGaD
Tenofovir—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000294	0.00123	CcSEcCtD
Tenofovir—Diarrhoea—Raloxifene—osteoporosis	0.000294	0.00123	CcSEcCtD
Tenofovir—Dyspepsia—Pamidronate—osteoporosis	0.000294	0.00123	CcSEcCtD
Tenofovir—Dizziness—Estropipate—osteoporosis	0.000294	0.00123	CcSEcCtD
Tenofovir—AK2—Metabolism—CYP27A1—osteoporosis	0.000292	0.00314	CbGpPWpGaD
Tenofovir—Diarrhoea—Ibandronate—osteoporosis	0.000291	0.00122	CcSEcCtD
Tenofovir—Anorexia—Zoledronate—osteoporosis	0.00029	0.00122	CcSEcCtD
Tenofovir—Decreased appetite—Pamidronate—osteoporosis	0.00029	0.00122	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.00029	0.00311	CbGpPWpGaD
Tenofovir—Mental disorder—Estradiol—osteoporosis	0.00029	0.00121	CcSEcCtD
Tenofovir—Dizziness—Alendronate—osteoporosis	0.000289	0.00121	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000288	0.00121	CcSEcCtD
Tenofovir—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000288	0.00121	CcSEcCtD
Tenofovir—Malnutrition—Estradiol—osteoporosis	0.000288	0.00121	CcSEcCtD
Tenofovir—Fatigue—Pamidronate—osteoporosis	0.000288	0.00121	CcSEcCtD
Tenofovir—Gastrointestinal pain—Risedronate—osteoporosis	0.000287	0.0012	CcSEcCtD
Tenofovir—Pain—Pamidronate—osteoporosis	0.000285	0.0012	CcSEcCtD
Tenofovir—Diarrhoea—Calcitriol—osteoporosis	0.000285	0.0012	CcSEcCtD
Tenofovir—Skin disorder—Conjugated Estrogens—osteoporosis	0.000285	0.0012	CcSEcCtD
Tenofovir—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000284	0.00119	CcSEcCtD
Tenofovir—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000284	0.00119	CcSEcCtD
Tenofovir—Dizziness—Raloxifene—osteoporosis	0.000284	0.00119	CcSEcCtD
Tenofovir—AK2—Metabolism—ACP5—osteoporosis	0.000284	0.00305	CbGpPWpGaD
Tenofovir—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000284	0.00119	CcSEcCtD
Tenofovir—Flatulence—Estradiol—osteoporosis	0.000283	0.00119	CcSEcCtD
Tenofovir—Vomiting—Estropipate—osteoporosis	0.000282	0.00118	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—WDR1—osteoporosis	0.000282	0.00303	CbGpPWpGaD
Tenofovir—Dizziness—Ibandronate—osteoporosis	0.000282	0.00118	CcSEcCtD
Tenofovir—Rash—Estropipate—osteoporosis	0.00028	0.00117	CcSEcCtD
Tenofovir—Dermatitis—Estropipate—osteoporosis	0.00028	0.00117	CcSEcCtD
Tenofovir—Anorexia—Conjugated Estrogens—osteoporosis	0.00028	0.00117	CcSEcCtD
Tenofovir—Back pain—Estradiol—osteoporosis	0.000278	0.00117	CcSEcCtD
Tenofovir—Headache—Estropipate—osteoporosis	0.000278	0.00117	CcSEcCtD
Tenofovir—Vomiting—Alendronate—osteoporosis	0.000278	0.00117	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000278	0.00116	CcSEcCtD
Tenofovir—Body temperature increased—Risedronate—osteoporosis	0.000277	0.00116	CcSEcCtD
Tenofovir—Abdominal pain—Risedronate—osteoporosis	0.000277	0.00116	CcSEcCtD
Tenofovir—Rash—Alendronate—osteoporosis	0.000276	0.00116	CcSEcCtD
Tenofovir—Insomnia—Zoledronate—osteoporosis	0.000276	0.00116	CcSEcCtD
Tenofovir—Dermatitis—Alendronate—osteoporosis	0.000275	0.00116	CcSEcCtD
Tenofovir—Headache—Alendronate—osteoporosis	0.000274	0.00115	CcSEcCtD
Tenofovir—Vomiting—Raloxifene—osteoporosis	0.000273	0.00115	CcSEcCtD
Tenofovir—Gastrointestinal pain—Pamidronate—osteoporosis	0.000273	0.00114	CcSEcCtD
Tenofovir—Dyspnoea—Zoledronate—osteoporosis	0.000272	0.00114	CcSEcCtD
Tenofovir—Rash—Raloxifene—osteoporosis	0.000271	0.00114	CcSEcCtD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.000271	0.00291	CbGpPWpGaD
Tenofovir—Dermatitis—Raloxifene—osteoporosis	0.000271	0.00114	CcSEcCtD
Tenofovir—Vomiting—Ibandronate—osteoporosis	0.000271	0.00114	CcSEcCtD
Tenofovir—Headache—Raloxifene—osteoporosis	0.000269	0.00113	CcSEcCtD
Tenofovir—Rash—Ibandronate—osteoporosis	0.000268	0.00113	CcSEcCtD
Tenofovir—Dermatitis—Ibandronate—osteoporosis	0.000268	0.00113	CcSEcCtD
Tenofovir—Dyspepsia—Zoledronate—osteoporosis	0.000268	0.00113	CcSEcCtD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.000267	0.00287	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000267	0.00112	CcSEcCtD
Tenofovir—NME1—Metabolism—FDPS—osteoporosis	0.000267	0.00287	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PKM—osteoporosis	0.000267	0.00287	CbGpPWpGaD
Tenofovir—Headache—Ibandronate—osteoporosis	0.000267	0.00112	CcSEcCtD
Tenofovir—Insomnia—Conjugated Estrogens—osteoporosis	0.000265	0.00111	CcSEcCtD
Tenofovir—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000265	0.00111	CcSEcCtD
Tenofovir—Vomiting—Calcitriol—osteoporosis	0.000265	0.00111	CcSEcCtD
Tenofovir—Decreased appetite—Zoledronate—osteoporosis	0.000265	0.00111	CcSEcCtD
Tenofovir—AK2—Metabolism—TPI1—osteoporosis	0.000264	0.00284	CbGpPWpGaD
Tenofovir—Nausea—Estropipate—osteoporosis	0.000264	0.00111	CcSEcCtD
Tenofovir—Body temperature increased—Pamidronate—osteoporosis	0.000264	0.00111	CcSEcCtD
Tenofovir—Abdominal pain—Pamidronate—osteoporosis	0.000264	0.00111	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000263	0.0011	CcSEcCtD
Tenofovir—Angioedema—Estradiol—osteoporosis	0.000263	0.0011	CcSEcCtD
Tenofovir—Rash—Calcitriol—osteoporosis	0.000263	0.0011	CcSEcCtD
Tenofovir—Fatigue—Zoledronate—osteoporosis	0.000263	0.0011	CcSEcCtD
Tenofovir—Dermatitis—Calcitriol—osteoporosis	0.000263	0.0011	CcSEcCtD
Tenofovir—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000262	0.0011	CcSEcCtD
Tenofovir—Headache—Calcitriol—osteoporosis	0.000261	0.0011	CcSEcCtD
Tenofovir—Pain—Zoledronate—osteoporosis	0.000261	0.00109	CcSEcCtD
Tenofovir—NME2—Metabolism—OXCT1—osteoporosis	0.00026	0.00279	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CA2—osteoporosis	0.00026	0.00279	CbGpPWpGaD
Tenofovir—Nausea—Alendronate—osteoporosis	0.00026	0.00109	CcSEcCtD
Tenofovir—Hypersensitivity—Risedronate—osteoporosis	0.000259	0.00108	CcSEcCtD
Tenofovir—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000258	0.00108	CcSEcCtD
Tenofovir—Asthenia—Ethinyl Estradiol—osteoporosis	0.000258	0.00108	CcSEcCtD
Tenofovir—Nausea—Raloxifene—osteoporosis	0.000255	0.00107	CcSEcCtD
Tenofovir—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000255	0.00107	CcSEcCtD
Tenofovir—Pruritus—Ethinyl Estradiol—osteoporosis	0.000255	0.00107	CcSEcCtD
Tenofovir—NME1—Metabolism—GPD2—osteoporosis	0.000253	0.00272	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PGLS—osteoporosis	0.000253	0.00272	CbGpPWpGaD
Tenofovir—NME2—Metabolism—MGLL—osteoporosis	0.000253	0.00272	CbGpPWpGaD
Tenofovir—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000253	0.00106	CcSEcCtD
Tenofovir—Fatigue—Conjugated Estrogens—osteoporosis	0.000253	0.00106	CcSEcCtD
Tenofovir—Nausea—Ibandronate—osteoporosis	0.000253	0.00106	CcSEcCtD
Tenofovir—Asthenia—Risedronate—osteoporosis	0.000252	0.00106	CcSEcCtD
Tenofovir—Pain—Conjugated Estrogens—osteoporosis	0.000251	0.00105	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000251	0.00269	CbGpPWpGaD
Tenofovir—Gastrointestinal pain—Zoledronate—osteoporosis	0.000249	0.00105	CcSEcCtD
Tenofovir—AK2—Metabolism—P4HB—osteoporosis	0.000248	0.00267	CbGpPWpGaD
Tenofovir—Pruritus—Risedronate—osteoporosis	0.000248	0.00104	CcSEcCtD
Tenofovir—Nausea—Calcitriol—osteoporosis	0.000248	0.00104	CcSEcCtD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000247	0.00265	CbGpPWpGaD
Tenofovir—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000246	0.00103	CcSEcCtD
Tenofovir—Hypersensitivity—Pamidronate—osteoporosis	0.000246	0.00103	CcSEcCtD
Tenofovir—Chest pain—Estradiol—osteoporosis	0.000245	0.00103	CcSEcCtD
Tenofovir—Myalgia—Estradiol—osteoporosis	0.000245	0.00103	CcSEcCtD
Tenofovir—Arthralgia—Estradiol—osteoporosis	0.000245	0.00103	CcSEcCtD
Tenofovir—Anxiety—Estradiol—osteoporosis	0.000244	0.00102	CcSEcCtD
Tenofovir—AK2—Metabolism—GAPDH—osteoporosis	0.000244	0.00262	CbGpPWpGaD
Tenofovir—CYP1A2—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000244	0.00262	CbGpPWpGaD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000243	0.00102	CcSEcCtD
Tenofovir—Abdominal pain—Zoledronate—osteoporosis	0.000241	0.00101	CcSEcCtD
Tenofovir—Body temperature increased—Zoledronate—osteoporosis	0.000241	0.00101	CcSEcCtD
Tenofovir—Diarrhoea—Risedronate—osteoporosis	0.00024	0.00101	CcSEcCtD
Tenofovir—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00024	0.00101	CcSEcCtD
Tenofovir—Asthenia—Pamidronate—osteoporosis	0.000239	0.001	CcSEcCtD
Tenofovir—Dizziness—Ethinyl Estradiol—osteoporosis	0.000238	0.000998	CcSEcCtD
Tenofovir—AK2—Metabolism—RAP1A—osteoporosis	0.000237	0.00255	CbGpPWpGaD
Tenofovir—Pruritus—Pamidronate—osteoporosis	0.000236	0.00099	CcSEcCtD
Tenofovir—Dizziness—Risedronate—osteoporosis	0.000232	0.000973	CcSEcCtD
Tenofovir—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000232	0.000973	CcSEcCtD
Tenofovir—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000232	0.000973	CcSEcCtD
Tenofovir—NME1—Metabolism—ATIC—osteoporosis	0.000232	0.00249	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PNP—osteoporosis	0.000232	0.00249	CbGpPWpGaD
Tenofovir—Nervous system disorder—Estradiol—osteoporosis	0.00023	0.000966	CcSEcCtD
Tenofovir—Vomiting—Ethinyl Estradiol—osteoporosis	0.000229	0.00096	CcSEcCtD
Tenofovir—Diarrhoea—Pamidronate—osteoporosis	0.000228	0.000957	CcSEcCtD
Tenofovir—Skin disorder—Estradiol—osteoporosis	0.000228	0.000957	CcSEcCtD
Tenofovir—Hyperhidrosis—Estradiol—osteoporosis	0.000227	0.000952	CcSEcCtD
Tenofovir—Rash—Ethinyl Estradiol—osteoporosis	0.000227	0.000952	CcSEcCtD
Tenofovir—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000227	0.000951	CcSEcCtD
Tenofovir—Headache—Ethinyl Estradiol—osteoporosis	0.000225	0.000946	CcSEcCtD
Tenofovir—Hypersensitivity—Zoledronate—osteoporosis	0.000224	0.000942	CcSEcCtD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.000223	0.0024	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—CAP1—osteoporosis	0.000223	0.0024	CbGpPWpGaD
Tenofovir—Vomiting—Risedronate—osteoporosis	0.000223	0.000936	CcSEcCtD
Tenofovir—Rash—Risedronate—osteoporosis	0.000221	0.000928	CcSEcCtD
Tenofovir—Dermatitis—Risedronate—osteoporosis	0.000221	0.000927	CcSEcCtD
Tenofovir—Dizziness—Pamidronate—osteoporosis	0.000221	0.000925	CcSEcCtD
Tenofovir—Headache—Risedronate—osteoporosis	0.00022	0.000922	CcSEcCtD
Tenofovir—Asthenia—Zoledronate—osteoporosis	0.000219	0.000917	CcSEcCtD
Tenofovir—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000216	0.000907	CcSEcCtD
Tenofovir—Pruritus—Zoledronate—osteoporosis	0.000216	0.000904	CcSEcCtD
Tenofovir—NME2—Metabolism—IDH2—osteoporosis	0.000215	0.00231	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000214	0.000897	CcSEcCtD
Tenofovir—Nausea—Ethinyl Estradiol—osteoporosis	0.000214	0.000897	CcSEcCtD
Tenofovir—Insomnia—Estradiol—osteoporosis	0.000212	0.000891	CcSEcCtD
Tenofovir—Vomiting—Pamidronate—osteoporosis	0.000212	0.00089	CcSEcCtD
Tenofovir—Asthenia—Conjugated Estrogens—osteoporosis	0.00021	0.000883	CcSEcCtD
Tenofovir—Rash—Pamidronate—osteoporosis	0.00021	0.000882	CcSEcCtD
Tenofovir—Dermatitis—Pamidronate—osteoporosis	0.00021	0.000882	CcSEcCtD
Tenofovir—Dyspnoea—Estradiol—osteoporosis	0.000209	0.000878	CcSEcCtD
Tenofovir—Headache—Pamidronate—osteoporosis	0.000209	0.000877	CcSEcCtD
Tenofovir—Diarrhoea—Zoledronate—osteoporosis	0.000208	0.000875	CcSEcCtD
Tenofovir—Nausea—Risedronate—osteoporosis	0.000208	0.000874	CcSEcCtD
Tenofovir—Pruritus—Conjugated Estrogens—osteoporosis	0.000208	0.000871	CcSEcCtD
Tenofovir—Dyspepsia—Estradiol—osteoporosis	0.000207	0.000867	CcSEcCtD
Tenofovir—Decreased appetite—Estradiol—osteoporosis	0.000204	0.000856	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Estradiol—osteoporosis	0.000203	0.00085	CcSEcCtD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.000203	0.00218	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CYP27A1—osteoporosis	0.000203	0.00218	CbGpPWpGaD
Tenofovir—Fatigue—Estradiol—osteoporosis	0.000202	0.000849	CcSEcCtD
Tenofovir—Dizziness—Zoledronate—osteoporosis	0.000201	0.000845	CcSEcCtD
Tenofovir—Pain—Estradiol—osteoporosis	0.000201	0.000842	CcSEcCtD
Tenofovir—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000201	0.000842	CcSEcCtD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.0002	0.00215	CbGpPWpGaD
Tenofovir—Nausea—Pamidronate—osteoporosis	0.000198	0.000831	CcSEcCtD
Tenofovir—NME2—Metabolism—ACP5—osteoporosis	0.000197	0.00212	CbGpPWpGaD
Tenofovir—NME1—Metabolism—OXCT1—osteoporosis	0.000197	0.00212	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CA2—osteoporosis	0.000197	0.00212	CbGpPWpGaD
Tenofovir—Dizziness—Conjugated Estrogens—osteoporosis	0.000194	0.000814	CcSEcCtD
Tenofovir—Vomiting—Zoledronate—osteoporosis	0.000194	0.000813	CcSEcCtD
Tenofovir—Rash—Zoledronate—osteoporosis	0.000192	0.000806	CcSEcCtD
Tenofovir—Gastrointestinal pain—Estradiol—osteoporosis	0.000192	0.000806	CcSEcCtD
Tenofovir—AK2—Metabolism—ENO1—osteoporosis	0.000192	0.00206	CbGpPWpGaD
Tenofovir—NME1—Metabolism—MGLL—osteoporosis	0.000192	0.00206	CbGpPWpGaD
Tenofovir—Dermatitis—Zoledronate—osteoporosis	0.000192	0.000805	CcSEcCtD
Tenofovir—Headache—Zoledronate—osteoporosis	0.000191	0.000801	CcSEcCtD
Tenofovir—AK2—Metabolism—PSMA5—osteoporosis	0.000189	0.00203	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PSMA2—osteoporosis	0.000189	0.00203	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—IGF1—osteoporosis	0.000188	0.00202	CbGpPWpGaD
Tenofovir—Vomiting—Conjugated Estrogens—osteoporosis	0.000187	0.000783	CcSEcCtD
Tenofovir—Abdominal pain—Estradiol—osteoporosis	0.000186	0.000779	CcSEcCtD
Tenofovir—Body temperature increased—Estradiol—osteoporosis	0.000186	0.000779	CcSEcCtD
Tenofovir—Rash—Conjugated Estrogens—osteoporosis	0.000185	0.000776	CcSEcCtD
Tenofovir—Dermatitis—Conjugated Estrogens—osteoporosis	0.000185	0.000775	CcSEcCtD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.000184	0.00198	CbGpPWpGaD
Tenofovir—Headache—Conjugated Estrogens—osteoporosis	0.000184	0.000771	CcSEcCtD
Tenofovir—NME2—Metabolism—TPI1—osteoporosis	0.000183	0.00197	CbGpPWpGaD
Tenofovir—Nausea—Zoledronate—osteoporosis	0.000181	0.000759	CcSEcCtD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	0.000179	0.00193	CbGpPWpGaD
Tenofovir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000179	0.00192	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—MGLL—osteoporosis	0.000177	0.0019	CbGpPWpGaD
Tenofovir—Nausea—Conjugated Estrogens—osteoporosis	0.000174	0.000731	CcSEcCtD
Tenofovir—Hypersensitivity—Estradiol—osteoporosis	0.000173	0.000726	CcSEcCtD
Tenofovir—NME2—Metabolism—P4HB—osteoporosis	0.000172	0.00185	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GAPDH—osteoporosis	0.000169	0.00182	CbGpPWpGaD
Tenofovir—Asthenia—Estradiol—osteoporosis	0.000168	0.000707	CcSEcCtD
Tenofovir—Pruritus—Estradiol—osteoporosis	0.000166	0.000697	CcSEcCtD
Tenofovir—ABCC4—NRF2 pathway—AGER—osteoporosis	0.000165	0.00177	CbGpPWpGaD
Tenofovir—NME2—Metabolism—RAP1A—osteoporosis	0.000165	0.00177	CbGpPWpGaD
Tenofovir—NME1—Metabolism—IDH2—osteoporosis	0.000163	0.00175	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PLEK—osteoporosis	0.000162	0.00174	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—ANXA2—osteoporosis	0.000162	0.00174	CbGpPWpGaD
Tenofovir—Diarrhoea—Estradiol—osteoporosis	0.000161	0.000674	CcSEcCtD
Tenofovir—CYP1A2—Tryptophan metabolism—CYP19A1—osteoporosis	0.00016	0.00172	CbGpPWpGaD
Tenofovir—Dizziness—Estradiol—osteoporosis	0.000155	0.000651	CcSEcCtD
Tenofovir—AK2—Metabolism—CYP19A1—osteoporosis	0.000153	0.00165	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CYP27A1—osteoporosis	0.000153	0.00165	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000151	0.00162	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.00015	0.00161	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ACP5—osteoporosis	0.000149	0.0016	CbGpPWpGaD
Tenofovir—Vomiting—Estradiol—osteoporosis	0.000149	0.000626	CcSEcCtD
Tenofovir—Rash—Estradiol—osteoporosis	0.000148	0.000621	CcSEcCtD
Tenofovir—Dermatitis—Estradiol—osteoporosis	0.000148	0.000621	CcSEcCtD
Tenofovir—Headache—Estradiol—osteoporosis	0.000147	0.000617	CcSEcCtD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000146	0.00157	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000145	0.00155	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.00014	0.00151	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.00014	0.00151	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TLN1—osteoporosis	0.00014	0.0015	CbGpPWpGaD
Tenofovir—Nausea—Estradiol—osteoporosis	0.000139	0.000585	CcSEcCtD
Tenofovir—ABCC2—NRF2 pathway—AGER—osteoporosis	0.000139	0.00149	CbGpPWpGaD
Tenofovir—NME1—Metabolism—TPI1—osteoporosis	0.000139	0.00149	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—VCL—osteoporosis	0.000138	0.00148	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ENO1—osteoporosis	0.000133	0.00143	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PSMA5—osteoporosis	0.000131	0.00141	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PSMA2—osteoporosis	0.000131	0.00141	CbGpPWpGaD
Tenofovir—NME1—Metabolism—P4HB—osteoporosis	0.00013	0.0014	CbGpPWpGaD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.00013	0.00139	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GAPDH—osteoporosis	0.000128	0.00138	CbGpPWpGaD
Tenofovir—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000128	0.00138	CbGpPWpGaD
Tenofovir—AK2—Metabolism—ADCY5—osteoporosis	0.000125	0.00135	CbGpPWpGaD
Tenofovir—AK2—Metabolism—GPX1—osteoporosis	0.000125	0.00134	CbGpPWpGaD
Tenofovir—NME1—Metabolism—RAP1A—osteoporosis	0.000125	0.00134	CbGpPWpGaD
Tenofovir—CYP1A2—Arachidonic acid metabolism—GPX1—osteoporosis	0.000122	0.00131	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000122	0.00131	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000118	0.00127	CbGpPWpGaD
Tenofovir—AK2—Metabolism—MTHFR—osteoporosis	0.000115	0.00124	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—RAP1A—osteoporosis	0.000115	0.00124	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—TGFB1—osteoporosis	0.000113	0.00121	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	0.000107	0.00115	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	0.000107	0.00115	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CYP19A1—osteoporosis	0.000106	0.00114	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP27A1—osteoporosis	0.000106	0.00114	CbGpPWpGaD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000105	0.00113	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP27A1—osteoporosis	0.000105	0.00113	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—FGA—osteoporosis	0.000104	0.00112	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ENO1—osteoporosis	0.000101	0.00108	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PSMA5—osteoporosis	9.94e-05	0.00107	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PSMA2—osteoporosis	9.94e-05	0.00107	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—FGB—osteoporosis	9.5e-05	0.00102	CbGpPWpGaD
Tenofovir—AK2—Metabolism—POMC—osteoporosis	9.22e-05	0.000991	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ADCY5—osteoporosis	8.69e-05	0.000934	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GPX1—osteoporosis	8.66e-05	0.000931	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—IGF1—osteoporosis	8.35e-05	0.000897	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CYP19A1—osteoporosis	8.06e-05	0.000866	CbGpPWpGaD
Tenofovir—NME2—Metabolism—MTHFR—osteoporosis	7.99e-05	0.000859	CbGpPWpGaD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	7.79e-05	0.000838	CbGpPWpGaD
Tenofovir—ABCC4—Ectoderm Differentiation—MYC—osteoporosis	7.31e-05	0.000786	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	7.15e-05	0.000769	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	7.11e-05	0.000764	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—TGFB1—osteoporosis	6.97e-05	0.000749	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	6.74e-05	0.000724	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ADCY5—osteoporosis	6.59e-05	0.000708	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GPX1—osteoporosis	6.56e-05	0.000705	CbGpPWpGaD
Tenofovir—NME2—Metabolism—POMC—osteoporosis	6.39e-05	0.000687	CbGpPWpGaD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.32e-05	0.000679	CbGpPWpGaD
Tenofovir—NME1—Metabolism—MTHFR—osteoporosis	6.06e-05	0.000651	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—TGFB1—osteoporosis	5.88e-05	0.000632	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	5.59e-05	0.0006	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	5.57e-05	0.000599	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	5.56e-05	0.000597	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	5.51e-05	0.000592	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.49e-05	0.00059	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.26e-05	0.000566	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	5.24e-05	0.000563	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	5.19e-05	0.000558	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	5.19e-05	0.000558	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	5.11e-05	0.000549	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	5e-05	0.000538	CbGpPWpGaD
Tenofovir—NME1—Metabolism—POMC—osteoporosis	4.85e-05	0.000521	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.58e-05	0.000492	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.44e-05	0.000477	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IGF1—osteoporosis	4.3e-05	0.000462	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.08e-05	0.000439	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.47e-05	0.000373	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—POMC—osteoporosis	3.36e-05	0.000361	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—FDPS—osteoporosis	3.17e-05	0.00034	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PKM—osteoporosis	3.17e-05	0.00034	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PGLS—osteoporosis	3e-05	0.000322	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GPD2—osteoporosis	3e-05	0.000322	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ATIC—osteoporosis	2.74e-05	0.000295	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PNP—osteoporosis	2.74e-05	0.000295	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TGFB1—osteoporosis	2.58e-05	0.000277	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—OXCT1—osteoporosis	2.33e-05	0.000251	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CA2—osteoporosis	2.33e-05	0.000251	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—MGLL—osteoporosis	2.27e-05	0.000244	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.14e-05	0.00023	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—IDH2—osteoporosis	1.93e-05	0.000208	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.82e-05	0.000195	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ACP5—osteoporosis	1.77e-05	0.00019	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.75e-05	0.000188	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—TPI1—osteoporosis	1.64e-05	0.000177	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—P4HB—osteoporosis	1.55e-05	0.000166	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GAPDH—osteoporosis	1.52e-05	0.000163	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—RAP1A—osteoporosis	1.48e-05	0.000159	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.29e-05	0.000138	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ENO1—osteoporosis	1.19e-05	0.000128	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PSMA2—osteoporosis	1.18e-05	0.000127	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PSMA5—osteoporosis	1.18e-05	0.000127	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP19A1—osteoporosis	9.55e-06	0.000103	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ADCY5—osteoporosis	7.8e-06	8.39e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GPX1—osteoporosis	7.78e-06	8.36e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—MTHFR—osteoporosis	7.18e-06	7.71e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—POMC—osteoporosis	5.74e-06	6.17e-05	CbGpPWpGaD
